-
Something wrong with this record ?
Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination
SJ. McKie, AS. Nicholson, E. Smith, S. Fawke, ER. Caroe, JC. Williamson, BG. Butt, D. Kolářová, O. Peterka, M. Holčapek, PJ. Lehner, SC. Graham, JE. Deane
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
219447/Z/19/Z
Wellcome Trust (WT)
MR/N020626/1
UKRI | Medical Research Council (MRC)
210688/Z/18/Z
Wellcome Trust (WT)
NLK
Free Medical Journals
from 1915 to 6 months ago
Freely Accessible Science Journals
from 1915 to 6 months ago
PubMed Central
from 1915 to 6 months ago
Europe PubMed Central
from 1915 to 6 months ago
Open Access Digital Library
from 1915-01-15
Open Access Digital Library
from 1915-01-01
- MeSH
- Demyelinating Diseases * pathology MeSH
- Glycosphingolipids metabolism MeSH
- Humans MeSH
- Cell Adhesion Molecules metabolism MeSH
- Myelin Sheath metabolism MeSH
- Nerve Growth Factors metabolism MeSH
- Sulfoglycosphingolipids * MeSH
- Carrier Proteins metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Myelin is a multilayered membrane that tightly wraps neuronal axons, enabling efficient, high-speed signal propagation. The axon and myelin sheath form tight contacts, mediated by specific plasma membrane proteins and lipids, and disruption of these contacts causes devastating demyelinating diseases. Using two cell-based models of demyelinating sphingolipidoses, we demonstrate that altered lipid metabolism changes the abundance of specific plasma membrane proteins. These altered membrane proteins have known roles in cell adhesion and signaling, with several implicated in neurological diseases. The cell surface abundance of the adhesion molecule neurofascin (NFASC), a protein critical for the maintenance of myelin-axon contacts, changes following disruption to sphingolipid metabolism. This provides a direct molecular link between altered lipid abundance and myelin stability. We show that the NFASC isoform NF155, but not NF186, interacts directly and specifically with the sphingolipid sulfatide via multiple binding sites and that this interaction requires the full-length extracellular domain of NF155. We demonstrate that NF155 adopts an S-shaped conformation and preferentially binds sulfatide-containing membranes in cis, with important implications for protein arrangement in the tight axon-myelin space. Our work links glycosphingolipid imbalances to disturbance of membrane protein abundance and demonstrates how this may be driven by direct protein-lipid interactions, providing a mechanistic framework to understand the pathogenesis of galactosphingolipidoses.
Department of Analytical Chemistry University of Pardubice Pardubice 53210 Czech Republic
Department of Pathology University of Cambridge Cambridge CB2 1QP UK
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010498
- 003
- CZ-PrNML
- 005
- 20230801132448.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1073/pnas.2218823120 $2 doi
- 035 __
- $a (PubMed)36996106
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a McKie, Shannon J $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
- 245 10
- $a Altered plasma membrane abundance of the sulfatide-binding protein NF155 links glycosphingolipid imbalances to demyelination / $c SJ. McKie, AS. Nicholson, E. Smith, S. Fawke, ER. Caroe, JC. Williamson, BG. Butt, D. Kolářová, O. Peterka, M. Holčapek, PJ. Lehner, SC. Graham, JE. Deane
- 520 9_
- $a Myelin is a multilayered membrane that tightly wraps neuronal axons, enabling efficient, high-speed signal propagation. The axon and myelin sheath form tight contacts, mediated by specific plasma membrane proteins and lipids, and disruption of these contacts causes devastating demyelinating diseases. Using two cell-based models of demyelinating sphingolipidoses, we demonstrate that altered lipid metabolism changes the abundance of specific plasma membrane proteins. These altered membrane proteins have known roles in cell adhesion and signaling, with several implicated in neurological diseases. The cell surface abundance of the adhesion molecule neurofascin (NFASC), a protein critical for the maintenance of myelin-axon contacts, changes following disruption to sphingolipid metabolism. This provides a direct molecular link between altered lipid abundance and myelin stability. We show that the NFASC isoform NF155, but not NF186, interacts directly and specifically with the sphingolipid sulfatide via multiple binding sites and that this interaction requires the full-length extracellular domain of NF155. We demonstrate that NF155 adopts an S-shaped conformation and preferentially binds sulfatide-containing membranes in cis, with important implications for protein arrangement in the tight axon-myelin space. Our work links glycosphingolipid imbalances to disturbance of membrane protein abundance and demonstrates how this may be driven by direct protein-lipid interactions, providing a mechanistic framework to understand the pathogenesis of galactosphingolipidoses.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a sulfoglykosfingolipidy $7 D013433
- 650 _2
- $a glykosfingolipidy $x metabolismus $7 D006028
- 650 _2
- $a transportní proteiny $x metabolismus $7 D002352
- 650 _2
- $a neurotrofní faktory $x metabolismus $7 D009414
- 650 _2
- $a myelinová pochva $x metabolismus $7 D009186
- 650 _2
- $a molekuly buněčné adheze $x metabolismus $7 D015815
- 650 12
- $a demyelinizační nemoci $x patologie $7 D003711
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nicholson, Alex S $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
- 700 1_
- $a Smith, Emily $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK $1 https://orcid.org/0000000224196146
- 700 1_
- $a Fawke, Stuart $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK
- 700 1_
- $a Caroe, Eve R $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK $1 https://orcid.org/000000033529024X
- 700 1_
- $a Williamson, James C $u Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0AW, UK
- 700 1_
- $a Butt, Benjamin G $u Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK
- 700 1_
- $a Kolářová, Denisa $u Department of Analytical Chemistry, University of Pardubice, Pardubice 53210, Czech Republic $1 https://orcid.org/000000033749625X
- 700 1_
- $a Peterka, Ondřej $u Department of Analytical Chemistry, University of Pardubice, Pardubice 53210, Czech Republic
- 700 1_
- $a Holčapek, Michal $u Department of Analytical Chemistry, University of Pardubice, Pardubice 53210, Czech Republic $1 https://orcid.org/0000000339781249 $7 ola2002159192
- 700 1_
- $a Lehner, Paul J $u Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge CB2 0AW, UK $1 https://orcid.org/0000000193831054
- 700 1_
- $a Graham, Stephen C $u Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK $1 https://orcid.org/0000000345474034
- 700 1_
- $a Deane, Janet E $u Department of Clinical Neuroscience, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK $1 https://orcid.org/0000000248630330
- 773 0_
- $w MED00010472 $t Proceedings of the National Academy of Sciences of the United States of America $x 1091-6490 $g Roč. 120, č. 14 (2023), s. e2218823120
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36996106 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132445 $b ABA008
- 999 __
- $a ok $b bmc $g 1963114 $s 1196763
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 120 $c 14 $d e2218823120 $e 20230330 $i 1091-6490 $m Proceedings of the National Academy of Sciences of the United States of America $n Proc Natl Acad Sci U S A $x MED00010472
- GRA __
- $a 219447/Z/19/Z $p Wellcome Trust (WT)
- GRA __
- $a MR/N020626/1 $p UKRI | Medical Research Council (MRC)
- GRA __
- $a 210688/Z/18/Z $p Wellcome Trust (WT)
- LZP __
- $a Pubmed-20230718